Theresa McCrumb
Nurse Practitioner · Kalamazoo, MINPI 1548925050
Payments from drug & device makers
Across 53 payments — averaging $55.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novartis$152
- Sanofi-aventis U.S. LLC$117
- Xeris Pharmaceuticals, Inc.$80
- Lilly USA, LLC$74
- Biohaven Pharmaceutical Holding Company Ltd.$62
- plus $490 from 16 others
What the payments were for
- Consulting fees$1,35046%
- Travel & lodging$37013%
- Food & beverage$1,23042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $1,976 |
| Novartis | 3 | $152 |
| Sanofi-aventis U.S. LLC | 3 | $117 |
| Xeris Pharmaceuticals, Inc. | 4 | $80 |
| Lilly USA, LLC | 4 | $74 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $62 |
| Bristol Myers Squibb | 3 | $61 |
| Insulet Corporation | 3 | $59 |
| Pfizer | 3 | $49 |
| Novo Nordisk | 2 | $48 |
| Biogen | 2 | $42 |
| Boehringer Ingelheim | 2 | $39 |
| Medtronic | 1 | $31 |
| Argenx US, Inc. | 1 | $22 |
| Averitas Pharma Inc. | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Radius Health, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| Abbott | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
How this compares
$2,950 in reported general payments places this provider in the 90th percentile of 3,351 nurse practitioner providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 188 | $208,087 |
| JardianceEmpagliflozin | 215 | $201,115 |
| OzempicSemaglutide | 102 | $113,403 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 31 | $82,064 |
| FarxigaDapagliflozin Propanediol | 42 | $44,434 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $36,403 |
| TrulicityDulaglutide | 18 | $28,052 |
| JanuviaSitagliptin Phosphate | 34 | $23,487 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 108 | $21,110 |
| Tresiba Flextouch U-100Insulin Degludec | 22 | $20,782 |
| Novolog FlexpenInsulin Aspart | 26 | $14,672 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 23 | $11,590 |
| Gvoke Hypopen 2-PackGlucagon | 16 | $9,620 |
| Humalog Kwikpen U-100Insulin Lispro | 27 | $8,570 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 19 | $5,651 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $74 | $239,692218 claims |
| Boehringer IngelheimJardiance | $39 | $201,115215 claims |
| Novo NordiskOzempic, Novolog | $48 | $118,003116 claims |
| PfizerLevoxyl | $49 | $94571 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Kalamazoo
- Melanie SlofferKalamazoo$26K
- Margot ChadwickKalamazoo$10K
- Kelly BeckerKalamazoo$10K
- Davida KrugerDetroit$1.8M
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.